Teva Rise: Global Open Innovation Platform to Accelerate Breakthroughs for Pharma’s Biggest Challenges

Sparking innovation to ignite change and make a real difference to patients: Teva Rise aims to harness the power of global talent, emerging technologies and cross-industry partnerships, aligned with Teva’s unique heritage of high-quality generics and growing biopharmaceutical innovation.

How does it work?

A global taskforce led by sponsors – senior leaders - and catalysts – innovation ambassadors - within Teva business units have identified critical business challenges to share externally through the Rise platform, seeking innovative and disruptive technologies. 

Each challenge reflects real-world business priorities and will be sponsored by a senior business leader at Teva. These challenges will be broadcasted throughout the global tech ecosystem to gather solution proposals. The most compelling ideas progress to a pilot phase to validate their value. Partners selected during the open call will have the possibility to pilot their solution with Teva, gaining access to a powerful platform to test, scale and measure their solutions, turning ideas into real-world healthcare innovations alongside one of the industry’s leaders.

In line with Teva’s strategic Accelerating Growth phase, a substantial investment is planned to adopt innovative solutions and advanced technologies across tech sectors including health-tech, artificial intelligence and advanced manufacturing.

What are the benefits for partners?

Teva Rise offers the ultimate launchpad for scalable innovation. As a global pharma leader with 37,000 industry experts, 48 manufacturing and 21 R&D sites across 26 countries serving 57 markets, Teva offers access to a complete pharma value chain, with a support ecosystem that includes scientific expertise, operational excellence, regulatory and manufacturing infrastructure, data, logistics, and market access. 

Teva’s support ecosystem includes scientific expertise, operational excellence, regulatory and manufacturing infrastructure, data, logistics, and market access. By joining Teva Rise, partners gain a powerful platform to test, scale and measure their solutions, turning ideas into real-world healthcare innovations alongside one of the industry’s leaders. The Rise initiative is the bridge for this, identifying the challenges to launch with the business units, driving the solution selection process and providing full funding for the startups for pilot and integration.

“This is an exciting first for Teva. By partnering with start-ups across the globe, we can unlock smarter solutions and innovation. Through Teva Rise, we are forging global partnerships with start-ups and technology leaders, channeling tens of millions of dollars into solutions that will not only strengthen our business but also deliver meaningful value to patients worldwide. By embracing open innovation and investing ambitiously, we are building a sustainable competitive advantage for Teva and shaping the future of healthcare."
Mark Sabag, EVP International Markets and global sponsor